Qube Research & Technologies (QRT)
DMRA

Qube Research & Technologies (QRT)’s Damora Therapeutics DMRA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-282,436
Closed -$7.32M – 3703
2026
Q1 		$7.32M Buy
+282,436
New +$7.26M 0.01% 1469

Other funds holding DMRA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RCP
Remedium Capital Partners Fort Lauderdale, Florida $452M AUM

Qube Research & Technologies (QRT)'s DMRA Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Damora Therapeutics (DMRA) in Q2 2026, closing a stake of 282,436 shares — an estimated $7.32M sold.

Qube Research & Technologies (QRT) first reported a position in DMRA in Q1 2026 and held it in 1 quarter. The position peaked at $7.32M in Q1 2026. 104 funds tracked by Wall St. Rank hold DMRA as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Damora Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 282,436 Damora Therapeutics shares in Q2 2026, an estimated $7.32M.
  • Qube Research & Technologies (QRT) first reported a position in Damora Therapeutics in Q1 2026 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Damora Therapeutics position peaked at $7.32M in Q1 2026.
  • 104 funds tracked by Wall St. Rank held Damora Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.